CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE17177.50225.25 (+1.33 %)
PREV CLOSE () 16952.25
OPEN PRICE () 17290.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 970
TODAY'S LOW / HIGH ()17018.95 17400.00
52 WK LOW / HIGH ()11500 19748.4
NSE17198.00225 (+1.33 %)
PREV CLOSE() 16973.00
OPEN PRICE () 17122.00
BID PRICE (QTY) 17198.00 (2)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35209
TODAY'S LOW / HIGH() 16981.00 17400.00
52 WK LOW / HIGH ()11500 19747
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone : 040-67611600 / 67611700

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
05Jun Neuland Laboratories informs about in
Neuland Laboratories has informed that the Company’s management will be..
13May Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
29Apr Neuland Laboratories submits earnings
Neuland Laboratories has informed that the company will announce its res..
14Apr Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
14Apr Neuland Laboratories informs about pre
Neuland Laboratories has informed that it enclosed copies of newspaper a..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit2125.233631.05
Gross Profit 2870.42 4877.34
Operating Profit 3193.66034.09
Net Sales 7762.520229.85
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
NGL Fine-Chem (BSE)
 3063.60 (12.85%)
M.Cap ( in Cr)
1892.70
Abbott India (BSE)
 26272.05 (0.76%)
M.Cap ( in Cr)
55826.27
Senores Pharmaceutic (BSE)
 1291.25 (11.35%)
M.Cap ( in Cr)
5946.67
Kwality Pharma (BSE)
 2497.00 (5.24%)
M.Cap ( in Cr)
2590.94
Procter&Gamble Healt (BSE)
 6273.55 (1.39%)
M.Cap ( in Cr)
10413.71
Shareholding Pattern
PROMOTERS 32.63%
NON-INSTITUTION 31.07%
MUTUAL FUNDS/UTI 11.35%
FI/BANKS/INSURANCE 1.3%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX75527.951695.40 (2.30%)
NIFTY23622.90461.30 (1.99%)
Dow Jones 51202.26353.51 (0.70%)
Nasdaq 25888.8479.18 (0.31%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI